Juraj Bodo
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 29, 2025
Angioimmunoblastic T-cell lymphoma: Characterization of clonal T and B cells and a patient-derived xenograft study of coexisting T- and B-cell proliferation.Xiaoxian Zhao, Deepa Jagadeesh, Juraj Bodo
|Jan 04, 2025
Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia.Luca Guarnera, Carmelo Gurnari, Carlos Bravo-Perez
|Jul 18, 2022
Inhibition of cyclin-dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphoma.Xiaoxian Zhao, Juraj Bodo, Ruoying Chen
|Nov 09, 2021
Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies.Isha Kapoor, Juraj Bodo, Brian T Hill
|Nov 03, 2020
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance.Isha Kapoor, Juraj Bodo, Brian T Hill
|May 23, 2018
SLAMF7 (CD319/CS1) is expressed in plasmablastic lymphoma and is a potential diagnostic marker and therapeutic target.John Shi, Juraj Bodo, Xiaoxian Zhao
Pageof 1
Frequent Collaborators
2 joint publications
Alexandru Almasan
2 joint publications
Xiaoxian Zhao
1 joint publications
Carlos Bravo-Perez
1 joint publications
Arda Durmaz
1 joint publications
Hussein Awada
1 joint publications
Olisaemeka D Ogbue
1 joint publications
Jaroslaw P Maciejewski
1 joint publications
Valeria Visconte
1 joint publications
Eric D Hsi
